Diabetes, Heart and Cardiovascular Diseases News Chronicle.  Diabetes, Cardiovascular and Heart Diseases
 Article 62
    Published on September 23, 2016


About Fast Acting Insulin Drug NovoRapid

European drug committee issued a positive assessment for the usage of NovoRapid drug (manufactured by Danish company Novo Nordisk) for the diabetes treatment to children above 1 year. NovoRapid is an insulin aspart, a fast-acting insulin which can be absorbed quickly into the bloodstream. European Commission may issue the final regulatory decision within two months.




       
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK on your social media is (copy and paste the code below) :

Articles similar to this topic


1. Discovery Of Fast Acting Insulin Of Conus Geographus
2. Discovery Gene Destroying Insulin-Producing Cells
3. Device To Release Drugs In Eye
4. Device To Predict Diabetes
5. Trials Of GLP-1 (exenatide extended-release) And Farxiga (dapagliflozin)

 

NovoRapid : NovoRapid (insulin aspart) drug manufactured by Novo Nordisk to treat diabetes for an individual over two years. This drug is available in more than 120 countries.

Novo Nordisk : Novo Nordisk is a multinational pharmaceutical company having headquarters in Denmark. They market products under the brands Novolin R, Levemir, NovoSeven, NovoLog, NovoEight and Victoza. Key products of the company are

  • Insulin pumps
  • Insulin pens
  • Insulin Degludec (Tresiba) : Basal insulin for the treatment of type 1 (T1D) type 2 diabetes (T2D)
  • Ryzodeg : A soluble combined drug of Tresiba and NovoRapid, a rapid-acting mealtime insulin
  • Liraglutide 3 Mg (Saxenda) : GLP-1

 

Link Between Gestational Diabetes And Depression

A study done by researchers from the National Institutes of Health says two-way link exists between depression and diabetes and both of them occur together. But the study failed to show cause and relationship between depression and diabetes. Researchers analyzed 2,477 pregnant women data and found that


Dr. Stefanie Hinkle participated in the research work, a staff scientist in the Division of Intramural Population Health Research and the study results were published in the journal Diabetologia.




       
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK on your social media is (copy and paste the code below) :

Articles similar to this topic


1. Study Of Gestational Diabetes (GD)
2. Risks With Gestational Diabetes After Birth
3. Genetic Link Between Diabetes And Depression
4. Diabetes Link To Depression
5. Storing Body Fat More efficiently

 

Trimesters : Trimester is a measure of pregnancy. Pregnancy period (40 weeks) contains three trimesters. They are

  • 1st week to 12th week is the first trimester
  • 13th week to 27th week is the second trimester
  • 27th week to the birth of the child is the third trimester

 

About Continuous Glucose Monitoring (CGM) Devices

Global Continuous Glucose Monitoring (CGM) devices market is dominated by Abbott Laboratories, DexCom Incorporation and Medtronic. Continuous Glucose Monitoring (CGM) devices are for type 1 diabetes (T1D) patients as they face risks with hypoglycemia and hyperglycemia conditions and early detection of them is required. Usage of CGM devices is increasing due to increase in the population of patients with type 1 diabetes (T1D), obesity and sedentary lifestyle of humans. Manufacturers are facing some challenges as they could not able to improve accuracy in the CGM data. Available CGM devices in the market are


  • Dexcom G4 Platinum CGM and Dexcom Seven Plus CGM from Dexcom, San Diego, California, United States
  • Freestyle Libre, Freestyle Navigator and Freestyle Navigator 2 from Abbott Laboratories, Chicago, Illinois, United States
  • Medtronic Enlite Sensor and Medtronic Guardian REAL-Time from Medtronic, Dublin, Republic of Ireland



       
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK on your social media is (copy and paste the code below) :

Articles similar to this topic


1. Devices To Read Glucose Levels In Perspiration
2. Devices From Medtronic
3. About Cybersecurity For Diabetes Devices
4. Device To Detect Deadly Ketones
5. About Revita DMR Device

 

Continuous glucose monitoring : Continuous glucose monitoring (CGM) devices measure an individual's glucose levels in real-time continuously. These devices measure glucose levels from the fluid in and around your skin cells and not from the bloodstream. CGM devices are less invasive. A disposable glucose sensor inserted in tissue fluid under skin reads glucose levels. A wireless transmitter is connected to the glucose sensor to send data to signal receiver and display device. Diabetes patients and healthcare professionals can get better and complete picture of sugar levels with CGMs and helps in taking prompt and better decisions on medications. Some CGM devices even alert patient before sugar levels reach limits. The 2015 NICE guidelines for the management of type 1 diabetes (T1D) recommends usage of CGM devices for type 1 diabetes (T1D) as they suffer from hypoglycemia.

 

 

Site maps

Site map 1   Site map 2   Site map 3   Site map 4


The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. Published article is not a medical advice by the OWNER of "Diabetes News Chronicle" website or by the AUTHOR of the article.


Published by Jammi Vasista, Chennai, India.
Email Jammi[no-space]Vasista1991[at]gmail[dot]com
Phone 91-944-578-3182.
Address Diabetes News Chronicle, No 40, Kaveri Street, Rajaji Nagar, Villivakkam, Chennai, India. Pin : 600049.